Drug
2,4-thiazolidinedione clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 2
- first study started
- 2001
How studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 2
Stanford University (1) · GlaxoSmithKline (1) · University of Wisconsin, Madison (1) · Sanofi (1)
Often tested with
Tested in the same studies.
Sulfonylurea Antidiabetic Agent (1) · N,N''-sulfonylbis-urea (1) · Biguanides (1) · Glycoside Hydrolase Inhibitors (1) · Metformin (1)
Studies
Open first, then newest update. How each study uses 2,4-thiazolidinedione is read from its arms, and is right about nine times in ten.
Testing it · 4
- Integrating the Genetic and Metabolic Faces of ObesityCompletedPhase 1Stanford UniversityNCT00285844Written as thiazolidinedione
- A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedPhase 3GlaxoSmithKlineNCT01777282Written as Thiazolidinedione
- Islet Transplantation in Type 1 Diabetic PatientsCompletedPhase 1University of Wisconsin, MadisonNCT00214253Written as Thiazolidinedione
- Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other TreatmentCompletedPhase 3SanofiNCT00046462Written as Thiazolidinedione
Given in every arm · 3 — 2,4-thiazolidinedione is usual care beside what is tested
- Add-on to Thiazolidinedione (TZD) FailuresCompletedPhase 3AstraZenecaNCT00683878Written as Thiazolidinedione (Pioglitazone)
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineCompletedPhase 3SanofiNCT00975286Written as Thiazolidinedione (TZD)
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01468181Written as Thiazolidinedione (TZD)
As the comparator · 1 — what is tested is compared with 2,4-thiazolidinedione
Codes
What other systems call 2,4-thiazolidinedione · ClinicalTrials.gg INT003805
- MeSH (NLM) C0899462,4-thiazolidinedioneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) AA68LXK93C2,4-THIAZOLIDINEDIONEConfirmed NLM, Wikidata
- Wikidata Q13935562,4-thiazolidinedioneConfirmed NLM, Wikidata
- DrugBank DB11898One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C089946 | 2,4-thiazolidinedione | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | AA68LXK93C | 2,4-THIAZOLIDINEDIONE | Confirmed NLM, Wikidata |
| Wikidata | Q1393556 | 2,4-thiazolidinedione | Confirmed NLM, Wikidata |
| DrugBank | DB11898 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.